Medulla Expands Global Footprint with Strategic Launch in ...
Europa Schluss: Kaum Impulse - Kursrutsch bei Orsted
Aktien Europa: Wenig Bewegung nach starker Vorwoche - Warten ...
KI in der klinischen Krebsforschung: Novartis und Friedrich-Alexander-Universität ...
Aktien Europa: Wenig Bewegung zum Wochenausklang - Versicherer ...
Global Biotechnology Market Outlook 2025: Driving Growth ...
Acne Vulgaris Market to Register Sustainable Growth by 2034 ...
Illuccix® PSMA-PET-beeldvormingsagens voor prostaatkanker ...
Global Nuclear Magnetic Resonance Spectroscopy Market is ...
Clarivate Identifies Radioligand Therapy Innovators as Companies ...
Topical Drug Delivery Market is expected to generate a revenue ...
2024 Access to Medicine Index zeigt dass Pharmaunternehmen ...
L indice 2024 sur l accès aux médicaments révèle que ...
Oncology Drugs Market worth $520 billion by 2033 - Exclusive ...
Appian verkĂĽndet die Gewinner der Innovation Awards 2025 ...
Shanghai Argo Announces Multi-Program RNAi Licenses and ...
Vivet Therapeutics receives EUR 4.9 million to advance development ...
Sjogren's Syndrome Market to Register Sustainable Growth ...
Kidney Transplant Market to Surpass US$ 106.18 Billion by ...
Cardiovascular Drugs Market Size & Share to Surpass USD ...
Market Logic revolutionizes market intelligence data analysis ...
Présentation de la liste des intervenants du Fortune Global ...
Telix Illuccix® PSMA-PET-Bildgebungsmittel in Deutschland ...
Spinal Cord Injury Market Likely to Exhibit Substantial ...
Illuccix® Prostate Cancer PSMA-PET Imaging Agent Approved ...
Telix's Illuccix® PSMA-PET Imaging Agent Approved in Germany ...
Department of Health - Abu Dhabi and Novartis to Partner ...
Dawn Health y Novartis lanzan Cora BC para el apoyo del ...
Prostatakrebs-PSMA-PET-Bildgebungsmittel Illuccix® in Österreich ...
Achondroplasia Treatment Drug Market to Register Positive ...
iOnctura bolsters leadership team with new appointments. ...
Neurofibromatosis Type 2 Market to Observe Impressive Growth ...
Dawn Health et Novartis lancent Cora BC pour le soutien ...
NYSE Content Advisory: Pre-Market update + Wall Street reopens ...
Metastatic Prostate Cancer Market to Exhibit Positive Growth ...
Down's Syndrome Market to Exhibit Growth at a CAGR of 3.81% ...
Telix's Illuccix® PSMA-PET Imaging Agent Approved in Portugal ...
Regenerative Medicine Market Worth $49.0 Billion | MarketsandMarkets™. ...
Illuccix® Prostate Cancer Imaging Agent Approved in Luxembourg ...
AI4HealthyCities: Novartis Foundation reveals potential ...
CAR T-cell Therapy Market worth $29.0 billion by 2029 driven ...
Traumatic Brain Injury Market to Expand at a CAGR of 10.9% ...
Triple-Negative Breast Cancer Market Gearing Up for Impressive ...
Immunotherapy Drugs Market worth $580.6 billion by 2029 ...
Der Veeva European Commercial Summit versammelt fĂĽhrende ...
Peanut Allergy Market Set to Grow at a 16% CAGR During the ...
APPIS 2024: Healthcare Stakeholders Come Together to Prioritize ...
Get Ready for Next Generation of Diabetes Weight-Management ...
Disposable Contact Lenses Market worth $14.93 Bn by 2031 ...
Tony Kouzarides Founder of STORM Therapeutics Awarded British ...
Oligonucleotide Synthesis Market Worth $19.7 billion | MarketsandMarkets™ ...
Telix's Illuccix PSMA-PET Imaging Agent Approved in France ...
Illuccix® PSMA-PET-kontrastmedel för prostatacancer godkänt ...
Tent France s agrandit et compte désormais 45 grandes entreprises unies pour soutenir l ...
By 2029 the Autologous Stem Cell & Non-stem Cell Therapies ...
Dawn Health and Novartis Launch Cora BC for Breast Cancer ...
Sironax Grants Novartis Exclusive Option to Acquire its ...
Paul Holmes and Global Experts at the Online Davos Communications ...
Tent France Grows to 45 Major Companies United in Helping ...
Fortune Global Forum: Rednerliste fĂĽr den 11. und 12. November ...
Abzena Announces Establishment of Scientific Advisory Board ...
Telix's Illuccix® PSMA-PET Imaging Agent Approved in Norway ...
Dawn Health und Novartis starten Cora BC zur UnterstĂĽtzung ...
Global Immunomodulator Market Valuation Set to Total a Staggering ...
Dry Age-related Macular Degeneration Seven Major Market ...
High Potency Drug Market worth USD 379.20 Billion by 2031 ...
L agent d imagerie Illuccix® pour le cancer de la prostate ...
Inherited Retinal Disease Market Size and Share to Grow ...
Illuccix Prostate Cancer PSMA-PET Imaging Agent Approved ...
Vicebio Advances Clinical Study of RSV/hMPV Bivalent Vaccine ...
Radiopharmaceuticals Market to Reach $11.6 Billion by 2034 ...
Chronic Inflammatory Demyelinating Polyneuropathy Market ...
ISOMORPHIC LABS ANNOUNCES STRATEGIC MULTI-TARGET RESEARCH ...
T-cell Therapy Market Size to Grow USD US$ 76.6 billion ...
Alkermes Announces Appointment of Nancy S. Lurker to Board ...
LoQus23 Therapeutics announces ÂŁ35 million Series A financing ...
Novartis' VANRAFIA Approval Disrupts IgA Nephropathy Market ...
Sarcoidosis Market to Register Incremental Growth During ...
Clarivate Report Reveals Top Trademark Portfolios
Beyond the Horizon: Innovative Drug Combinations Offer New ...
Illuccix® Prostate Cancer PSMA-PET Imaging Agent Approved ...
eClinical Solutions Market worth $22.1 billion by 2029 driven ...
O ĂŤndice de Acesso a Medicamentos de 2024 constata que ...
Hidradenite supurativa ganha nova opção de tratamento ...
Você já ouviu falar sobre a atrofia muscular espinhal ...
Pacientes de câncer de mama aguardam publicação do Protocolo ...
El ĂŤndice de Acceso a los Medicamentos de 2024 revela que ...
Medison Pharma e Alnylam Pharmaceuticals anunciam expansĂŁo ...
Clarivate Identifies Radioligand Therapy Innovators as Companies ...
APPIS 2024: Healthcare Stakeholders Come Together to Prioritize ...
La Banque africaine de développement soutiendra le plan ...
Clarivate Report Reveals Top Trademark Portfolios
Europa Schluss: Durchwachsen - Börse Zürich unter Druck ...
Aktien Europa Schluss: Durchwachsene Entwicklung - Börse ...
ANALYSE-FLASH: Bernstein belässt Novartis auf Outperform ...
Zoll-Reaktion: Novartis will Zugang von Medikamenten verbessern ...